SS-31 Peptide Dosage: Research Protocol
SS-31, also known as elamipretide, is a mitochondria-targeting peptide studied for its effect on cellular energy. This guide collects the dosing ranges reported in research into a reference chart. Figures are research-reported and not dosing advice.
What makes SS-31 different
Most peptides act on receptors at the cell surface. SS-31 is unusual because it targets the inner mitochondrial membrane, where it interacts with a lipid called cardiolipin. That focus on the mitochondria, the energy factories of the cell, is why it is studied for conditions and contexts involving energy metabolism.
| Context | Reported dose | Frequency |
|---|---|---|
| Lower research range | 5 mg | Once daily |
| Common research range | 10 mg | Once daily |
| Cycle length | 4 to 8 weeks | then reassess |
SS-31 is given subcutaneously and dosed in milligrams. Convert your target into syringe units with the dosage calculator for your vial and water volume.
Handling and timing
SS-31 is reconstituted and handled like other subcutaneous peptides. See the reconstitution guide for method. Protocols often place the dose in the morning. Related mitochondrial and metabolic peptides are covered across the protocol library.
Accuracy first
As with any milligram-dosed peptide, consistent measurement is the priority. A chart is a reference point, not a substitute for drawing the same accurate dose each time.